The effects of reimbursement reform of antidiabetic medicines from the patients’ perspective – a survey among patients with type 2 diabetes in Finland

Table 3 The main categories and subcategories found in the study (N = 603)

Category	n^a	%
Economic effects	197	32.7
Increased expenditure	105	17.4
Difficulty in purchasing medicines	57	9.5
Purchasing medicines has required saving or borrowing money	52	8.6
Annoyance^b	75	12.4
Effects on use of medicines^b	46	7.6
More accurately undefined effect^b	13	2.2
Effects on health	8	1.3
Impaired therapeutic control	6	1.0
Impaired quality of life	2	0.3

ISSN: 1472-6963